Riskpilot← Back to searchSign inGet full accessNoid Health AB
ABActiveOrg 5569555872Göteborgsvägen 74Other human health activities n.e.c. · NACE 8699Est. 20135 employees
Revenue 2024
SEK 7,1M
+8% vs 2023
EBITDA margin
9.8%
+1% vs 2023
Equity ratio
37.7%
Financial strength
Net profit 2024
SEK 321K
-23% vs 2023
| Revenue | SEK 7,1M | +8% |
| EBITDA | SEK 697K | +1% |
| Net profit | SEK 321K | -23% |
| Total assets | SEK 4,8M | +19% |
| Equity | SEK 1,8M | +22% |
| Employees | 5 | — |
Legal name
Noid Health AB
Org number
5569555872
Legal form
Aktiebolag
NACE code
8699 · Other human health activities n.e.c.
Founded
18 december 2013
Share capital
SEK 50 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva verksamhet inom hälsa, hälsoanalyser och hälsobehandlingar, med inköp och försäljning av därtill erforderlig utrustning samt även bedriva föreläsningar, kursverksamhet, försäljning av kosttillskott, fastighetsförvaltning, förvaltning av värdepapper och försäljning av hudvårdsprodukter samt därmed förenlig verksamhet.
Address
Göteborgsvägen 74
Phone
+46708811282
Email
info@lundborgkliniken.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 7 005 | 6 912 | 7 475 | 6 626 | 7 145 |
| Staff expenses | — | — | — | — | −3 760 |
| EBITDA | 285 | 413 | 399 | 689 | 697 |
| Depreciation & amort. | −202 | −168 | −283 | −363 | −381 |
| EBIT | 83 | 245 | 116 | 326 | 316 |
| Net financials | −7 | −8 | −7 | −34 | −14 |
| Profit before tax | 97 | 5 | 178 | 520 | 410 |
| Tax | −22 | −5 | −0 | −105 | −88 |
| Net profit | 75 | 0 | 178 | 415 | 321 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 159 | 3 169 | — | 4 032 | 4 806 |
| Equity | 1 078 | 1 078 | — | 1 491 | 1 812 |
| Long-term debt | 247 | 247 | — | 247 | 247 |
| Short-term debt | 1 246 | 1 024 | — | 1 771 | 2 331 |
| Total debt | 1 493 | 1 271 | — | 2 018 | 2 578 |
EBITDA margin
9.8%
This company
15.8%
Market median
-38% vs market
20202024
Equity ratio
37.7%
This company
38.2%
Market median
+1% vs market
20202024
Return on equity
17.7%
This company
18.4%
Market median
+4% vs market
20202024
Net profit margin
4.5%
This company
8.1%
Market median
-44% vs market
20202024
Asset turnover
1.49×
This company
1.12×
Market median
+33% vs market
20202024
Debt / equity
1.65×
This company
0.62×
Market median
-166% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
KS Chief Executive Officer | Chief Executive Officer | 2022 |
KG | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Noid Health AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karin Suzanne Lundborg | Chief Executive Officer | 0 companies |
| Karl Gustav Håkan Kjellström | Audit | 0 companies |
| Jan Hugo Victor Lundborg | Deputy Board Member | 0 companies |